Content continues after advertisement

Pruritus in a Hyperthyroid Cat

Antonia Ioannou, BVMS, MRCVS, Cummings School of Veterinary Medicine at Tufts University

Orla Mahony, MVB, DACVIM & DECVIM, Tufts University Cummings School of Veterinary Medicine

Sign in to Print/View PDF

pruritus in a hyperthyroid cat

Figure Facial excoriations

Fleur, a 12-year-old spayed domestic shorthair cat, is presented for a one-week history of worsening pruritus. She was diagnosed with hyperthyroidism 6 weeks prior, and treatment with methimazole (2.5 mg/cat PO every 12 hours) was initiated at that time.

History

Fleur is an indoor-only cat. Her appetite is mildly decreased, but she eats regularly. She has no recent history of vomiting, diarrhea, coughing, sneezing, polyuria, or polydipsia. As a kitten, she was diagnosed with ocular keratitis secondary to feline herpesvirus type 1 infection.

Physical Examination

On physical examination, Fleur is bright, alert, and responsive. Temperature, pulse, and respiration are within normal limits. BCS is 4/9. There is a palpable thyroid slip, right-sided thyroid nodule, and grade II/VI parasternal heart murmur. She has bilateral hair loss and facial excoriations with no obvious signs of fleas or other ectoparasites (Figure).

How would you diagnose and treat this patient?

Treatment & Outcome

Methimazole is a thyroid peroxidase inhibitor that inhibits thyroid hormone synthesis by interfering with iodine incorporation into tyrosyl residues of thyroglobulin. The primary differential diagnosis for pruritus and facial excoriations in this patient was an adverse effect of methimazole treatment. Other methimazole-related idiosyncratic reactions were assessed via CBC to rule out blood dyscrasias and serum chemistry profile to rule out hepatopathy and evaluate changes in renal function. Urinalysis can help assess renal function but was not performed prior to CBC because of concerns for methimazole-induced thrombocytopenia.  

Methimazole administration adjustments (eg, switching to transdermal methimazole, reducing the amount of oral methimazole) can be considered in patients with GI upset secondary to methimazole; however, methimazole should be discontinued if facial excoriations, blood dyscrasias, or hepatopathy occur, as these adverse effects are not related to the dose.  

Methimazole was discontinued, and pruritus and facial excoriations resolved. Successful control of hyperthyroidism was achieved via radioactive iodine treatment administered after one month.

Suggested Reading

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy